These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 1297641

  • 21. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease.
    Tompson DJ, Vearer D.
    Clin Ther; 2007 Dec; 29(12):2654-66. PubMed ID: 18201581
    [Abstract] [Full Text] [Related]

  • 22. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y, Lee L, Somma R, Thompson G, Bakhtiar R, Lee J, Rekhi GS, Lau H, Sedek G, Hossain M.
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
    Martins ML, Pierossi MA, Moraes LA, Ribeiro W, Abbib Júnior E, Mendes GB, Poli A, De Nucci G, Muscará MN.
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
    [Abstract] [Full Text] [Related]

  • 25. Comparative bioavailability study on naproxen betainate sodium salt monohydrate and naproxen sodium salt in healthy volunteers.
    Marzo A, Monti N, Ripamonti M, Marzo P, Wool C, Cerutti R, Maggi GC.
    Arzneimittelforschung; 1997 Apr; 47(4):385-9. PubMed ID: 9150858
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the bioavailability of 250 and 500 mg divalproex sodium extended-release tablets in healthy volunteers.
    Dutta S, Zhang Y, Lee LL, O'Dea R.
    Biopharm Drug Dispos; 2004 Nov; 25(8):353-7. PubMed ID: 15378556
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R, Nolting A, Roy P, Fiske W, Benedek I, Abramowitz W.
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clopidogrel bioavailability: absence of influence of food or antacids.
    McEwen J, Strauch G, Perles P, Pritchard G, Moreland TE, Necciari J, Dickinson JP.
    Semin Thromb Hemost; 1999 Dec; 25 Suppl 2():47-50. PubMed ID: 10440423
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Absence of food effect on the extent of alprazolam absorption from an orally disintegrating tablet.
    Erdman K, Stypinski D, Combs M, Witt P, Stiles M, Pollock S.
    Pharmacotherapy; 2007 Aug; 27(8):1120-4. PubMed ID: 17655512
    [Abstract] [Full Text] [Related]

  • 32. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
    Dulac O, Alvarez JC.
    Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
    [Abstract] [Full Text] [Related]

  • 33. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR, Shah J.
    Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
    [Abstract] [Full Text] [Related]

  • 34. [Postprandial delay of drug absorption in a gitoformate model].
    Kubin S, Woodcock BG, Menke G, Rietbrock N.
    Arzneimittelforschung; 1987 Dec; 37(12):1376-8. PubMed ID: 3449065
    [Abstract] [Full Text] [Related]

  • 35. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF, Poo JL, Rosales-Sanchez O, Fuentes-Fuentes E, Cariño L, Burke-Fraga V, Namur S, Parra MG.
    Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
    [Abstract] [Full Text] [Related]

  • 36. Lack of influence of sulglycotide on naproxen bioavailability in healthy volunteers.
    Berté F, Feletti F, di Valserra MB, Nazzari M, Cenedese A, Cornelli U.
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):125-8. PubMed ID: 3410594
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparative bioavailability: influence of various diets on the bioavailability of indomethacin.
    Wallusch WW, Nowak H, Leopold G, Netter KJ.
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):40-4. PubMed ID: 631970
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparative bioavailability of two oral suspensions of naproxen sodium.
    Carrasco-Portugal Mdel C, Herrera JE, Reyes-García G, Medina-Santillán R, Flores-Murrieta FJ.
    Arzneimittelforschung; 2006 Jan; 56(8):589-92. PubMed ID: 17009840
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.